Partneringdesk Deals and Alliances In Central Nervous System Diseases

Partneringdesk deals and alliances in central nervous system diseases provides an in-depth view of over 1100 deals and alliances announced in central nervous system diseases between 2001 and 2006, in a clear and accessible PDF format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in central nervous system diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment of deal-making trends in the last five years identifying active partners tracking competitor activity benchmarking deals Partneringdesk deals and alliances in central nervous system diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in central nervous system diseases. Report scope The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage of Japanese deals courtesy of JCN Forecasts, projections, market estimates This report provides a series of charts with analyses detailing market trends in central nervous system diseases deal making over the period of 2001 to 2006. Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.

Additional Information

Who should buy the report
This report is essential reading for board and executive management, and individuals in:

• business development
• licensing/partnering
• deal making
• business strategy
• marketing and promotion
• distribution and manufacturing (including contract services).

Companies analyzed/mentioned
Abbott Laboratories
Argenta Discovery Ltd
AstraZeneca
Aventis
Bionomics Limited
CeNeS Pharmaceuticals plc
Cephalon Inc
Curis
Eisai Co Ltd
Elan Corporation plc
Eli Lilly and Company
GlaxoSmithKline
H Lundbeck
Integra LifeSciences
Janssen Pharmaceutica
Merck & Co Inc
Novartis AG
Nymox Pharmaceutical
Organon
Pfizer Inc
Psychiatric Genomics Inc
Roche
Serono SA
Thuris Corporation
Wyeth